Pharvaris N.V. — Company profile
Healthcare · Biotechnology · Switzerland
Last price 33.58 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.36B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Details
| Name | Pharvaris N.V. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 148 |
| Founded | 2015 |
| Ipo Date | 2021-02-05 |
| Ceo | Berndt Axel Modig |
| Country | Switzerland |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| Ipo Price | 20.00 |
| Isin | NL00150005Y4 |
| Cik | 1830487 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Berndt Axel Edvard Modig CPA, M.B.A. | Co-Founder, Chief Executive Officer and Executive Director |
| Dr. Peng Lu M.D., Ph.D. | President |
| David W. Nassif J.D. | Chief Financial Officer, Chief Legal Officer and Corporate Secretary |
| Anna Nijdam M.Sc., R.A. | Head of Strategic Finance and Principal Accounting Officer |
| Dr. Stefan Abele Ph.D. | Chief Technology Operations Officer |
| Annick Deschoolmeester | Chief Human Resources Officer |
| Dr. Anne A. Lesage Ph.D. | Chief Early Development Officer |
| Wim Souverijns Ph.D. | Chief Commercial Officer |
| Maggie Beller | Vice President and Head of Corporate and Investor Communications |
| Maryann Cimino | Director of Corporate Relations |
Contact
| Address | Grafenauweg 8, Zug, 6300, Switzerland |
| Phone | 31 712036410 |
| Website | https://pharvaris.com |